Inmune Bio, Inc. Annual Revenues in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Inmune Bio, Inc. quarterly/annual Revenues history and growth rate from 2017 to 2024.
  • Inmune Bio, Inc. Revenues for the quarter ending March 31, 2025 was $50K, a 257% increase year-over-year.
  • Inmune Bio, Inc. annual Revenues for 2024 was $14K, a 91% decline from 2023.
  • Inmune Bio, Inc. annual Revenues for 2023 was $155K, a 58.6% decline from 2022.
  • Inmune Bio, Inc. annual Revenues for 2022 was $374K, a 107% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14K -$141K -91% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 $155K -$219K -58.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 $374K +$193K +107% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $181K +$170K +1545% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $11K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2019-03-29
2017 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.